Xeloda and Electrocardiogram st segment elevation - a phase IV clinical study of FDA data

Among these 28 people:

How long have people been on Xeloda when they have Electrocardiogram st segment elevation? *

• < 1 month: 100 %
• 1 - 6 months: 0.0 %
• 6 - 12 months: 0.0 %
• 1 - 2 years: 0.0 %
• 2 - 5 years: 0.0 %
• 5 - 10 years: 0.0 %
• 10+ years: 0.0 %

What is the gender of people who have Electrocardiogram st segment elevation when taking Xeloda? *

• female: 48 %
• male: 52 %

What is the age of people who have Electrocardiogram st segment elevation when taking Xeloda? *

• 0-1: 0.0 %
• 2-9: 0.0 %
• 10-19: 0.0 %
• 20-29: 0.0 %
• 30-39: 4 %
• 40-49: 4 %
• 50-59: 16 %
• 60+: 76 %

What are other drugs people take besides Xeloda? *

1. Maxzide: 3 people, 10.71%
2. Lipitor: 3 people, 10.71%
3. Valsartan: 3 people, 10.71%
4. Tykerb: 3 people, 10.71%
5. Protonix: 3 people, 10.71%
6. Coreg: 3 people, 10.71%
7. Avandia: 3 people, 10.71%
8. Metformin: 3 people, 10.71%
9. Leucovorin Calcium: 3 people, 10.71%
10. Fluorouracil: 2 people, 7.14%

What are other side effects people have besides Electrocardiogram st segment elevation? *

1. Chest Pain: 16 people, 57.14%
2. Arteriospasm Coronary (spasm of the large- or medium-sized coronary arteries): 7 people, 25.00%
3. Nausea (feeling of having an urge to vomit): 6 people, 21.43%
4. Arrhythmias (irregular heartbeat): 5 people, 17.86%
5. Ventricular Fibrillation (abnormally irregular heart rhythm): 4 people, 14.29%
6. Electrocardiogram T Wave Inversion: 4 people, 14.29%
7. Hypotension (abnormally low blood pressure): 4 people, 14.29%
8. Cardiac Arrest: 3 people, 10.71%
9. Pain In Jaw: 3 people, 10.71%
10. Pulmonary Hypertension (increase in blood pressure in the lung artery): 3 people, 10.71%

What are the existing conditions these people have? *

1. High Blood Pressure: 3 people, 10.71%
2. Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 2 people, 7.14%
3. Rectal Cancer (cancer of rectum): 2 people, 7.14%
4. Heart Disease: 2 people, 7.14%
5. Breast Cancer Recurrent: 2 people, 7.14%
6. Type 2 Diabetes: 1 person, 3.57%
7. Prostate Cancer: 1 person, 3.57%
8. Platelet Aggregation Inhibition: 1 person, 3.57%
9. Pancreatic Carcinoma (pancreatic cancer): 1 person, 3.57%
10. Constipation: 1 person, 3.57%

Do you take Xeloda and have Electrocardiogram st segment elevation?

- Check whether Electrocardiogram st segment elevation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

---

---

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Xeloda:

Electrocardiogram st segment elevation treatments and more:

How severe was Electrocardiogram st segment elevation and when was it recovered:

• Electrocardiogram st segment elevation in Xeloda

Expand to all the drugs that have ingredients of capecitabine:

• Electrocardiogram st segment elevation and drugs with ingredients of capecitabine

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Xeloda:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies

• Pinto HP, Bhat RM, Shet D, Dandekeri S, "Compound mucocutaneous adverse effects of oral capecitabine in a patient", Indian dermatology online journal, 2014 Jan .
• Kang SM, Baek JY, Hwangbo B, Kim HY, Lee GK, Lee HS, "A case of capecitabine-induced sarcoidosis", Tuberculosis and respiratory diseases, 2012 Mar .
• Pinto HP, Bhat RM, Shet D, Dandekeri S, "Compound mucocutaneous adverse effects of oral capecitabine in a patient", Indian dermatology online journal, 2014 Jan .
• Kang SM, Baek JY, Hwangbo B, Kim HY, Lee GK, Lee HS, "A case of capecitabine-induced sarcoidosis", Tuberculosis and respiratory diseases, 2012 Mar .

---

How the study uses the data?

The study uses data from the FDA. It is based on capecitabine (the active ingredients of Xeloda) and Xeloda (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

---

---

Recent studies on eHealthMe:

• Drug interactions of Duoneb and Glucagon - 2 seconds ago
• Could Aspirin cause Dislocation Of Vertebra? - 5 seconds ago
• Drug interactions of Proair Hfa and Loteprednol Etabonate - 6 seconds ago
• Could Bactrim cause Drooling? - 7 seconds ago
• Could Pregabalin cause Orthostatic Intolerance? - 10 seconds ago
• Could Allegra cause Incoherent? - 13 seconds ago
• Drug interactions of Dexilant and Timolol - 28 seconds ago
• Drug interactions of Glycine and Soma - 32 seconds ago
• Could Cefdinir cause Anaphylaxis? - 36 seconds ago
• Could Sandostatin Lar cause Hemiparesis? - 38 seconds ago